Teladoc Health Reports Fourth-Quarter and Full-Year 2020 Results

Go back to Teladoc Health Reports Fourth-Quarter and Full-Year 2020 Results

Teladoc (TDOC) Q4 Revenue Tops Views, Offers Guidance

February 24, 2021 4:08 PM EST

Teladoc (NYSE: TDOC) reported Q4 EPS of ($3.07), may not compare to the analyst estimate of ($0.24). Revenue for the quarter came in at $383.3 million versus the consensus estimate of $378.93 million.

GUIDANCE:

Teladoc sees Q1 2021 revenue of $445-455 million, versus the consensus of $446 million.

EBITDA to... More